Shane Stone

Dr. Shane Stone serves as a Visitor/Contractor at the UWA Medical School, specifically affiliated with the Centre for Neuromuscular and Neurological Disorders (Perron Institute) at The University of Western Australia. His research spans multiple disciplines at the intersection of bioengineering, synthetic biology, and biomedical applications, with an h-index of 10 and 307 total citations according to Scopus metrics.

Dr. Stone's research interests focus on peptide-based applications, metabolic engineering, and synthetic biology approaches to improve nutritional science and medical treatments. His work particularly emphasizes isoflavonoid synthase, protein modeling, and the development of peptide-based cancer vaccines. He investigates how synthetic biology can transform traditional nutrition paradigms and improve flavonoid pharmacokinetics through methylation and glycosylation processes. His research fingerprint includes significant contributions to Peptides (100%), Capsid (63%), Plant-Based Food (63%), and Cell-Penetrating Peptide (63%) research areas.

Analysis of Dr. Stone's recent publications reveals a strong focus on bioengineering solutions for medical and nutritional challenges. His work bridges computational biology with practical applications in vaccine development and nutritional science, with his 2021 paper on synthetic biology for flavonoid pharmacokinetics receiving 51 Scopus citations - the highest among his recent works. The research demonstrates expertise in protein modeling, metabolic engineering, and the application of synthetic biology to address real-world health issues.

Dr. Stone has established significant collaborative networks, primarily with researchers Sajid, M. and Kaur, P., across multiple publications. His work contributes to UN Sustainable Development Goals through innovations in nutrition, health, and sustainable bioproduction methods, with research outputs shared by numerous X (formerly Twitter) users and attracting substantial readership on Mendeley.